US Patent Issued to Xencor on Aug. 4 for "Antigen binding domains that bind to mesothelin (MSLN)" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,341, issued on Aug. 4, was assigned to Xencor Inc. (Pasadena, Calif.).

"Antigen binding domains that bind to mesothelin (MSLN)" was invented by John R. Desjarlais (Pasadena, Calif.), Matthew Bernett (Monrovia, Calif.), Michael Hedvat (Encino, Calif.), Veronica Gusti Zeng (Monrovia, Calif.) and Matthew S. Faber (Monrovia, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Mesothelin (MSLN)."

The patent was filed on May 1, 2024, under Application No. 18/652,669.

*For further information, including images, charts and tabl...